Showing results (91-100 of 1,983) with videos related to
Sort By:
Pageof 199
Journal of Cancer Research and Therapeutics|March 8, 2024
Fragmentation patterns of cell-free DNA and somatic mutations in the urine of metastatic breast cancer patientsShaoyan Lin, Shusen Wang, Binghe XuBreast (Edinburgh, Scotland)|December 31, 2022
Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter studyJingtong Zhai, Xiaoying Sun, Fang Zhao, et al.Lung Cancer (Amsterdam, Netherlands)|February 10, 2009
Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with GefitinibFei Ma, Tong Sun, Yuankai Shi, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 9, 2015
[Comparison of the effectiveness of platinum-based chemotherapy versus non-platinum-based chemotherapy for triple-negative breast cancer with metastases confined to the lungs]Ruoxi Hong, Fei Ma, Xiuqing Shi, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|December 10, 2019
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer: A real-world retrospective study in Chinese patientsJihong Guo, Qing Li, Pin Zhang, et al.Thoracic Cancer|March 26, 2018
Analysis of the activity and safety of weekly low-dose bevacizumab-based regimens in heavily pretreated patients with metastatic breast cancerXiaoyu Zhai, Ruoxi Hong, Ying Fan, et al.Frontiers in Oncology|May 16, 2022
Chemotherapy Decision-Making and Survival Outcomes in Older Women With Early Triple-Negative Breast Cancer: Evidence From Real-World PracticeMeng Xiu, Pin Zhang, Qing Li, et al.Thoracic Cancer|July 4, 2023
A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancerYue Chai, Jiaxuan Liu, Mingxia Jiang, et al.Biomed Research International|June 14, 2021
Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast CancerYiqun Han, Jiayu Wang, Binghe XuCritical Reviews in Oncology/Hematology|June 4, 2021
Cutaneous adverse events associated with immune checkpoint blockade: A systematic review and meta-analysisYiqun Han, Jiayu Wang, Binghe XuPageof 199